It is also too early to know what impact quitting has on long-term health (Youmshajekian) Acknowledgements This piece was originally published in April 2025 by Lara Marks with the generous help of Svetlana Mojsov, Jens Holst and Richard Ng who read early drafts
Once daily injectable liraglutide (marketed as Victoza for T2DM and Saxenda for obesity) and once weekly injectable semaglutide (marketed as Ozempic for T2DM and Wegovy for obesity) are two additional GLP-1 analogues, sharing 97% and 94% amino acid homology to GLP-1, respectively [ Figure 2 , Table 1 ]
Can GLP-1 therapy be part of a longevity medicine plan
March 25, 2024 Glucagon-like peptide-1 (GLP-1) drugs for diabetes and weight loss represent the new wave of blockbuster drugs
Tirzepatide (Mounjaro, Zepbound) Mounjaro is approved for type 2 diabetes
A 2017 study by Tejera-Segura and colleagues showed RA patients often have hidden insulin resistance driven by chronic inflammation